OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence
Francesco Passamonti, Giovanni Corrao, Gastone Castellani, et al.
Blood Reviews (2021) Vol. 54, pp. 100914-100914
Closed Access | Times Cited: 16

Showing 16 citing articles:

Artificial intelligence in hematological diagnostics: Game changer or gadget?
Wencke Walter, Christian Pohlkamp, Manja Meggendorfer, et al.
Blood Reviews (2022) Vol. 58, pp. 101019-101019
Open Access | Times Cited: 36

Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies
Jeffrey Bettinger, Bruce Friedman
Palliative Medicine Reports (2024) Vol. 5, Iss. 1, pp. 70-80
Open Access | Times Cited: 5

Myelodysplastic neoplasm with del(11q). Rara Avis.
Robert Peter Gale
Leukemia Research (2025) Vol. 150, pp. 107664-107664
Closed Access

The role of randomized controlled trials, registries, observational databases in evaluating new interventions
Robert Peter Gale, Mei‐Jie Zhang, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 4, pp. 101523-101523
Open Access | Times Cited: 9

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
Barbara Mora, Francesco Passamonti
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 5, pp. 127-139
Open Access | Times Cited: 10

How should we interpret conclusions of TKI-stopping studies
Robert Peter Gale, Junren Chen
Leukemia (2023) Vol. 37, Iss. 12, pp. 2343-2345
Open Access | Times Cited: 5

A multimodal analysis of genomic and RNA splicing features in myeloid malignancies
Arda Durmaz, Carmelo Gurnari, Courtney E. Hershberger, et al.
iScience (2023) Vol. 26, Iss. 3, pp. 106238-106238
Open Access | Times Cited: 4

SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis
Pankit Vachhani, Sanam Loghavi, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 7, pp. 413-426
Closed Access | Times Cited: 1

Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities
Emma Fröling, Neda Rajaeean, Klara Sonnie Hinrichsmeyer, et al.
Pharmaceutical Medicine (2024)
Open Access | Times Cited: 1

Construction of a Prediction Model for Voriconazole-Induced Hepatotoxicity Based on Mixed-Effects Random Forest
Danyang Tong, Yu Wang, Jing Ma, et al.
Studies in health technology and informatics (2024)
Open Access

IMPLEMENTATION OF A BASE OF RULES FOR DIFFERENTIAL DIAGNOSIS OF CLINICAL AND HEMATOLOGICAL SYNDROMES BASED ON MORPHOLOGICAL CLASSIFICATION ALGORITHM
Indira Uvaliуeva, Aigerim Ismukhamedova, Saule Belginova, et al.
Scientific Journal of Astana IT University (2024), pp. 43-56
Open Access

Prognostic and Predictive Models in Myelofibrosis
Barbara Mora, Cristina Bucelli, Daniele Cattaneo, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 223-235
Open Access

Page 1

Scroll to top